Categories Retail, U.S. Markets News

FDA puts the heat on e-cig makers to curb teen vaping

The e-cigarette market witnessed a phenomenal growth mainly because the concept was popularized in a convincing manner. While many wannabe quitters found the idea intriguing, there have been concerns it could be the perfect recipe for yet another form of addiction.

While it didn’t take too long for vaping to become a fad among the youth, the authorities are slowly waking up to the danger involved. The FDA this week unleashed a crackdown against merchants who sell e-cigarettes to minors. As part of the drive, the agency sent warning letters to as many as 1,300 retailers who deal in the e-cig brands of Juul, Vuse, MarkTen, Blu, and Logic.

The FDA has sent warning letters to as many as 1,300 retailers who deal in five popular e-cig brands

Meanwhile, shares of the leading tobacco companies witnessed frenetic buying activity following the news Wednesday, sending the prices sharply higher.

The regulators are particularly concerned about the health hazards of flavored e-cigs. They have directed manufacturers of the leading brands, which account for the lion’s share of total e-cig sales, to come up with plans within 60 days to stop the ‘epidemic’ of vaping among teenagers.

The FDA is considering a revision of its compliance policy, with more stringent norms for approving the marketing applications of firms that fail to act upon the directive. It also plans to impose a ban on the production and sale of flavored nicotine liquid used in vaping devices, and recommend a review of the products.

WHO’s Bloomberg is all set to smoke out the tobacco giants

“The disturbing and accelerating trajectory of use we’re seeing in youth, and the resulting path to addiction, must end. The FDA cannot tolerate a whole generation of young people becoming addicted to nicotine as a tradeoff for enabling adults to access these products,” said FDA Commissioner Scott Gottlieb.

Still struggling to recover from the huge loss suffered in Mid-April, Philip Morris (PM) shares gained about 4% Wednesday, marking the biggest intraday gain in three years. Altria’s (MO) stock also got a strong boost after the FDA announcement and gained about 7%. The news evoked a similar response among the investors of British American Tobacco (BTI), resulting in a 6% rise in its stock price.

Most Popular

Thermo Fisher Scientific (TMO) Q4 earnings drop despite higher revenues

Thermo Fisher Scientific Inc. (NYSE: TMO) announced fourth-quarter 2022 financial results, reporting a double-digit fall in adjusted earnings and an increase in revenues. Fourth-quarter revenues increased 7% annually to $11.5

Altria Group (MO) Q4 2022 Earnings: Key financials and quarterly highlights

Altria Group Inc. (NYSE: MO) reported fourth quarter 2022 earnings results today. Net revenues decreased 2.3% year-over-year to $6.1 billion. Net earnings attributable to Altria increased 65.6% to $2.6 billion

AMD Earnings: Advanced Micro Devices Q4 revenue up 16%, profit drops

Semiconductor company Advanced Micro Devices, Inc. (NASDAQ: AMD) reported a decline in fourth-quarter earnings, despite an increase in revenues. Earnings, excluding special items, dropped to $0.69 per share in the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top